Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Georgia, Bardi"'
Autor:
Dimitra Pantou, Haroula Tsarouha, Anna Papadopoulou, Louiza Mahaira, Ioannis Kyriazoglou, Nikiforos Apostolikas, Sophia Markidou, Theoni Trangas, Nikos Pandis, Georgia Bardi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 5, Iss 1, Pp 23-31 (2003)
Unknown primary tumors (UPTs) represent an entity of great clinical and biological interest, whose origin cannot be determined even after medical workup. To better understand their pathogenesis by outlining their genetic composition, 20 UPTs were inv
Externí odkaz:
https://doaj.org/article/691ef39d8cd9408199bf58fda408899c
Autor:
Dee Dussault, Georgia Bardi
From the first yoga instructor to bring cannabis-enhanced yoga classes to North America, a groundbreaking guide to finding balance in our lives using the ancient method of mixing cannabis with spiritual practice.Yogis have been using cannabis to enha
Autor:
Evi Lianidou, Aliki Ntzifa, Martha Zavridou, Athanasios Kotsakis, Vasilis Georgoulias, Georgia Bardi, Pavlos Pollakis
Publikováno v:
Cancer Research. 78:4576-4576
Background: Patients with EGFRmt non-small cell lung cancer (NSCLC) develop resistance to first (erlotinib/ gefitinib) and second (afatinib) generation EGFR tyrosine kinase inhibitors (EGFR TKIs). Circulating tumor cells (CTCs) may be used as a poten
Autor:
S. Fischer, Peter L. Greenberg, Kazuma Ohyashiki, Ulrich Germing, Michelle M. LeBeau, Julie Schanz, Georgia Bardi, Bertil Johansson, Claudia Haferlach, G. Prescher, Ecclache, Detlef Haase, Francesc Sole, John M. Bennett, M. Slovak
Publikováno v:
Onkologie. 33:1-66
Autor:
Sverre Heim, Georgia Bardi
Publikováno v:
Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, Fourth Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::832121f40a05afc56d8563c261322c37
https://doi.org/10.1002/9781118795569.ch14
https://doi.org/10.1002/9781118795569.ch14
Autor:
Marina Stamatellou, Haroula Tsarouha, Kostas Papanastasiou, Anastasia Pouli, Nikos Pandis, Georgia Bardi, Theoni Trangas, Helen Rizou, Dimitra Pantou
Publikováno v:
Genes, Chromosomes and Cancer. 42:44-57
To investigate the genetic basis of the great heterogeneity observed in the clinical behavior of multiple myeloma (MM), a combined approach of G-banding, interphase fluorescence in situ hybridization (FISH), and multicolor FISH (M-FISH) was employed
Autor:
Nikos Pandis, Georgia Bardi, Theoni Trangas, Sophia Markidou, Anna Papadopoulou, Nikiforos Apostolikas, Haroula Tsarouha, Louiza Mahaira, Ioannis Kyriazoglou, Dimitra Pantou
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 5, Iss 1, Pp 23-31 (2003)
Unknown primary tumors (UPTs) represent an entity of great clinical and biological interest, whose origin cannot be determined even after medical workup. To better understand their pathogenesis by outlining their genetic composition, 20 UPTs were inv
Publikováno v:
Ousager, L B, Lothe, R A, Bardi, G, Fenger, C, Kronborg, O & Heim, S 2001, ' Assessments of clonal composition of colorectal adenomas by fish analysis of chromosomes 1, 7, 13 and 20 ', International Journal of Cancer, vol. 92, pp. 816-23 . https://doi.org/10.1002/ijc.1275
Chromosome banding analysis has shown that numerical aberrations, in particular gains of chromosomes 7, 13 and 20, are common in colorectal adenomas but cannot provide reliable information on the size of the abnormal clones in vivo. We examined inter
Autor:
Karl-Göran Tranberg, Antonio Maranon, Luis Antonio Parada, Bertil Johansson, Unne Stenram, Magnus Hallén, Georgia Bardi
Publikováno v:
Clinical and Experimental Metastasis. 17:471-479
To investigate if karyotypic features of secondary liver tumors may provide diagnostic information and if the cytogenetic patterns of primary and metastatic colorectal carcinomas (CRC) are different, 33 liver metastases were analyzed: 25 CRC, 4 small
Publikováno v:
Cancer Genetics and Cytogenetics. 106:66-71
The phenotypic progression of colorectal tumors is driven by their step-by-step acquisition of genomic alterations. These pathogenetically important mutations are at the same time markers of tumor clonality. The aim of this study was to describe the